Side-by-Side Comparison

USANA Health Sciences vs Nu Skin Enterprises

An honest comparison to help you choose the right opportunity

Feature Comparison

Overall Rating
2.4/5
Winner
2.3/5
Startup Cost
N/A
N/A
Tie
Residual Income
2.0
2.0
Tie
Simplicity
2.0
2.0
Tie
Transparency
3.0
Winner
2.5
Community & Support
3.0
Winner
2.5
Value for Money
2.0
2.0
Tie
Overall Rating
2.4/5
Winner
2.3/5

Detailed Breakdown

USANA Health Sciences

Pros

  • Publicly traded (NYSE: USNA) — financial transparency via SEC filings
  • Products generally well-regarded for quality and manufacturing standards
  • Strong presence in Asia Pacific markets
  • No required autoship order — flexible purchase structure

Cons

  • Revenue declining — $921M (2023) to $855M (2024), net earnings dropped from $63.8M to $42M
  • Binary compensation plan is complex and favors positioning over effort
  • Products significantly overpriced vs. comparable retail supplements
Read Full USANA Health Sciences Review →

Nu Skin Enterprises

Pros

  • Publicly traded company (NYSE: NUS) — financial transparency via SEC filings
  • Innovative product line including patented ageLOC skincare technology
  • Global presence in 50+ markets
  • Strong R&D investment compared to typical MLMs

Cons

  • FTC investigation history and significant regulatory settlements in China
  • Revenue has declined significantly — from $2.7B (2013) to under $2B in recent years
  • Complex compensation plan requiring monthly qualifying purchases
Read Full Nu Skin Enterprises Review →
Our Verdict

Winner: USANA Health Sciences

2.4

Based on our analysis, USANA Health Sciences edges out with an overall rating of 2.4 compared to Nu Skin Enterprises's 2.3. Both options have their merits, but USANA Health Sciences offers a stronger overall opportunity based on our evaluation criteria including compensation structure, product quality, and long-term viability.

Ready to Get Started with USANA Health Sciences?

Based on our analysis, USANA Health Sciences offers the best opportunity for success.